share_log

Apple's AirPods Pro 2 Bring 'Clinical-Grade Hearing Aid' Without The Stigma Or High Cost: Here's What People Have To Say

Apple's AirPods Pro 2 Bring 'Clinical-Grade Hearing Aid' Without The Stigma Or High Cost: Here's What People Have To Say

蘋果的AirPods Pro 2帶來了「臨床級助聽器」,沒有附帶的恥辱或高昂的費用:以下是人們對此的評論
Benzinga ·  09/10 04:01

On Monday, Apple Inc. (NASDAQ:AAPL) announced a new feature in its AirPods Pro 2, aiming to transform the hearing health experience. This feature will offer an end-to-end hearing health experience, including active Hearing Protection, a scientifically validated Hearing Test, and a clinical-grade Hearing Aid feature.

週一,蘋果公司(納斯達克股票代碼:AAPL)宣佈了其AirPods Pro 2的一項新功能,旨在改變聽力健康體驗。該功能將提供端到端的聽力健康體驗,包括主動聽力保護、經過科學驗證的聽力測試和臨床級助聽器功能。

What Happened: With an estimated 1.5 billion people worldwide suffering from hearing loss, as per the World Health Organization, Apple has developed a comprehensive solution focused on prevention, awareness, and assistance.

發生了什麼:根據世界衛生組織的數據,全球估計有15人患有聽力損失,Apple 開發了一種側重於預防、宣傳和援助的全面解決方案。

The Hearing Protection feature will help users avoid exposure to loud environmental noise, while the Hearing Test feature will allow users to check their hearing at home. The results of this test will be used to create a personalized hearing profile for each user.

聽力保護功能將幫助用戶避免暴露在較大的環境噪音中,而聽力測試功能將允許用戶在家中檢查聽力。該測試的結果將用於爲每位用戶創建個性化的聽力配置文件。

The typical prescription hearing aids cost $2,000 to $7,000 which makes them inaccessible to millions who need them.
In 2022, the FDA approved over the counter hearing aids. Now Apple's latest AirPods offer a hearing aid mode. Excited to see this technology become widely used! pic.twitter.com/ioI5KVbT5I

— Nick Mark MD (@nickmmark) September 9, 2024

典型的處方助聽器售價爲2,000至7,000美元,這使得數百萬有需要的人無法獲得它們。
2022年,美國食品藥品管理局批准了非處方助聽器。現在,蘋果最新的AirPods提供了助聽器模式。很高興看到這項技術被廣泛使用!pic.twitter.com/ioi5kvbt5I

— 尼克·馬克醫學博士 (@nickmmark) 2024 年 9 月 9 日

The Hearing Aid capability uses the personalized hearing profile to transform the AirPods Pro into a "clinical-grade hearing aid," boosting sounds in real-time to help users better engage in conversations and stay connected to their surroundings.

助聽器功能使用個性化聽力配置將 AirPods Pro 轉變爲 「臨床級助聽器」,實時增強聲音,幫助用戶更好地參與對話並與周圍環境保持聯繫。

The Hearing Test and Hearing Aid features are expected to receive marketing authorization from global health authorities soon, including the U.S. Food and Drug Administration, and will be available this fall in more than 100 countries and regions.

聽力測試和助聽器功能預計將很快獲得包括美國食品藥品監督管理局在內的全球衛生當局的上市許可,並將於今年秋天在100多個國家和地區上市。

AirPods Pro 2 adding a clinical grade hearing aid functionality: Awesome

— Marques Brownlee (@MKBHD) September 9, 2024

AirPods Pro 2 增加了臨床級助聽器功能:太棒了

— 馬克斯·布朗利 (@MKBHD) 2024 年 9 月 9 日

Why It Matters: This announcement follows a series of developments and hints in Apple's hearing health initiatives. In November 2022, a study published in the iScience journal suggested that AirPods Pro met four of five standards of personal sound amplification products, indicating their potential as a hearing assistive device.

爲何重要:該公告是在蘋果聽力健康計劃的一系列進展和提示之後發佈的。2022年11月,發表在iScience期刊上的一項研究表明,AirPods Pro符合個人聲音放大產品的五項標準中的四項,這表明它們作爲助聽設備的潛力。

The AirPods are now hearing aids, without the stigma of hearing aids.
If you have some hearing loss but don't want to be sporting hearing aids, you can now just throw in apple airpods and nobody is the wiser.

— Joseph Carlson (@joecarlsonshow) September 9, 2024

AirPods現在是助聽器,沒有助聽器的污名。
如果你有聽力損失但又不想使用助聽器,你現在可以直接把蘋果的airpods放進去,沒有人比這更聰明瞭。

— 約瑟夫·卡爾森 (@joecarlsonshow) 2024 年 9 月 9 日

In March, rumors circulated about the new "hearing aid mode" for AirPods Pro in the upcoming iOS 18 update, building on the existing Live Listen feature.

3月,有傳言稱AirPods Pro在即將推出的iOS 18更新中將採用新的 「助聽器模式」,該模式建立在現有的實時收聽功能的基礎上。

  • Mark Cuban Praises Elon Musk's AI Chatbot Grok For Answering Kamala Harris' POV On Immigration: 'I Think It's Accurate'
  • 馬克·庫班稱讚埃隆·馬斯克的人工智能聊天機器人 Grok 回答了賀錦麗關於移民的觀點:「我認爲這是準確的」

Image via Apple

圖片來自蘋果

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

免責聲明:此內容部分是在Benzinga Neuro的幫助下製作的,並由Benzinga編輯審查和發佈。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論